本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Sutro Biopharma Inc

17.20
+0.34002.02%
成交量:4.03萬
成交額:69.15萬
市值:2.85億
市盈率:-0.99
高:17.41
開:17.09
低:16.96
收:16.86
52周最高:43.85
52周最低:7.15
股本:1,656.72萬
流通股本:1,076.62萬
量比:0.37
換手率:0.37%
股息:- -
股息率:- -
每股收益(TTM):-17.3700
每股收益(LYR):-22.4900
淨資產收益率:-1810.01%
總資產收益率:-36.08%
市淨率:-2.76
市盈率(LYR):-0.76

資料載入中...

2023/03/30

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/30

重要事件披露

8-K - Current report
2023/02/27

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/24

重要事件披露

8-K - Current report
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/01

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/23

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/09

重要事件披露

8-K - Current report
2022/12/20

重要事件披露

8-K - Current report
2022/11/08

重要事件披露

8-K - Current report
2022/11/08

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/10/24

重要事件披露

8-K - Current report
2022/08/31

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/08/08

重要事件披露

8-K - Current report
2022/08/08

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/07/26

重要事件披露

8-K - Current report
2022/07/08

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals